Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3f6r | FMN | Flavodoxin |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3f6r | FMN | Flavodoxin | / | 1.000 | |
| 1bu5 | RBF | Flavodoxin | / | 0.579 | |
| 1c7f | FMN | Flavodoxin | / | 0.553 | |
| 1xyy | FMN | Flavodoxin | / | 0.520 | |
| 1j9g | FMN | Flavodoxin | / | 0.512 | |
| 3f6s | FMN | Flavodoxin | / | 0.506 | |
| 5xra | FMN | Cannabinoid receptor 1 | / | 0.506 | |
| 5tgz | FMN | Cannabinoid receptor 1 | / | 0.505 | |
| 4fx2 | FMN | Flavodoxin | / | 0.499 | |
| 1azl | FMN | Flavodoxin | / | 0.497 | |
| 4ara | C56 | Acetylcholinesterase | 3.1.1.7 | 0.489 | |
| 3f90 | FMN | Flavodoxin | / | 0.487 | |
| 1akr | FMN | Flavodoxin | / | 0.486 | |
| 5fx2 | FMN | Flavodoxin | / | 0.485 | |
| 4y7c | FMN | NADPH--cytochrome P450 reductase | / | 0.476 | |
| 1akw | FMN | Flavodoxin | / | 0.472 | |
| 1aku | FMN | Flavodoxin | / | 0.468 | |
| 2fx2 | FMN | Flavodoxin | / | 0.467 | |
| 1fx1 | FMN | Flavodoxin | / | 0.463 | |
| 1wsb | FMN | Flavodoxin | / | 0.459 | |
| 3n3a | FMN | Protein NrdI | / | 0.452 | |
| 4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.448 | |
| 4n82 | FMN | Ribonucleotide reductase (NrdI family protein), putative | / | 0.447 | |
| 1j9z | FMN | NADPH--cytochrome P450 reductase | / | 0.443 | |
| 3fkt | SII | Beta-secretase 1 | 3.4.23.46 | 0.442 | |
| 1odc | A8B | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
| 1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
| 3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.440 | |
| 4m0f | 1YK | Acetylcholinesterase | 3.1.1.7 | 0.440 |